# US 2021/0276965 A1 · Industrial process for the preparation of cariprazine

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0276965 A1
- Document ID: US20210276965A1
- Status: Published application
- Kind: A1
- Application number: 16/316,312
- Filed: 2017-07-07
- Published: 2021-09-09
- Earliest claimed: 2016-07-08
- Assignees: Richter Gedeon Nyrt.
- Applicants: Richter Gedeon Nyrt.
- Inventors: József Neu; Sándor Garadnay; Tamás Szabó
- Web page: https://patentgrep.com/patent/US20210276965A1

## CPC

- C07D 295/06: substituted by halogen atoms or nitro radicals
- C07D 295/135: with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- A61P 25/18: Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07C 229/48: with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
- C07C 275/26: having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

In the process of the present invention, cariprazine is prepared by converting (trans-4-amino-cyclohexyl)-acetic acid ethyl ester hydrochloride to trans-4-aminocyclohexyl) acetic acid or its hydrochloride by hydrolysis, from the obtained product with addition of dimethylcarbamoyl derivative as a suitable reagent (trans-4-{[(dimethylamino)carbonyl]amino}cyclohexyl) acetic acid is formed, then the obtained compound is linked to 1-{2,3-dichlorophenyl)˜piperazine in the presence of carboxylic acid activating coupling reagent, and so 1,1-dimethyl-3-[trans-4-(2-oxo-2-(4-(2,3-dichlorophenyl)piperazin-1-yl-ethyl)cyclohexyl] urea is formed, which is converted to cariprazine borane adduct of formula (2) in the presence of reducing agent, and finally the product itself is eliminated directly or is obtained from its salt by a known method. The invention also relates to a group of intermediate compounds that are formed and/or used in the process according to the present invention.

## Claims

### Claim 1

A process for the preparation of cariprazine
wherein:
a) (trans-4-amino-cyclohexyl)-acetic acid ethyl ester hydrochloride is converted to trans-4-aminocyclohexyl) acetic acid or its hydrochloride by hydrolysis,
b) from the obtained product with addition of dimethylcarbamoyl derivative as a suitable reagent in the presence of alkaline reagent (trans-4 {[(dimethylamino)carbonyl]amino}cyclohexyl) acetic acid is formed,
c) then the obtained compound is linked to 1-(2,3-dichlorophenyl)-piperazine in the presence of a carboxylic acid activating coupling reagent, and 1,1-dimethyl-3-[trans-4-(2-oxo-2-(4-(2,3-dichlorophenyl)piperazin-1-yl-ethyl)cyclohexyl] urea is formed,
d) which is converted to cariprazine borane adduct of formula (2),
in the presence of a reducing agent, and
e) the final product itself is eliminated directly or is obtained from its salt by a known method.

### Claim 2 (depends on 1)

The process according to claim 1 characterized by carrying out the hydrolysis of (trans-4-amino-cyclohexyl)-acetic acid ethyl ester hydrochloride by basic or acidic hydrolysis.

### Claim 3 (depends on 1)

The process according to claim 1 characterized in that (trans-4-{[{dimethylamino)carbonyl]amino}cyclohexyl)-acetic acid is formed with dimethyl-carbamoyl chloride as reagent.

### Claim 4 (depends on 1)

The process according to claim 1 characterized in that the carboxylic acid activating coupling reagent for coupling of 1-(2,3-dichlorophenyl)-piperazine is a dehydrating agent.

### Claim 5 (depends on 1)

The process according to claim 1 characterized in that carbonyldiimidazole or thionyl chloride is used for the coupling reaction with 1-(2,3-dichlorophenyl)-piperazine.

### Claim 6 (depends on 1)

The process according to claim 1 characterized in that the reducing agent is formed in situ from a suitable precursor.

### Claim 7 (depends on 1)

The process according to claim 1 characterized in that borohydrides or boranes or complexes thereof having the corresponding counter ion are used as reducing agent.

### Claim 8 (depends on 7)

The process according to claim 7 characterized in that the borane complex is a complex of borane formed with Lewis bases, such as complexes formed with ethers, thioethers, amines, or a complex formed with tetrahydrofuran.

### Claim 9 (depends on 7)

The process according to claim 7 characterized in that the suitable counter ion for borohydrides are positive ions of metallic elements such as alkali metals, alkaline earth metals, earth metals, or aluminum.

### Claim 10 (depends on 1)

The process according to claim 1 characterized in that after isolation of the cariprazine borane adduct, carprazine salts are obtained by decomposition with Brönsted acids in conventional solvents.

### Claim 11 (depends on 10)

The process according to claim 10 characterized in that after isolation of_thg cariprazine borane adduct, the_Brönsted acid used for decomposition in conventional solvents is hydrogen chloride.

### Claim 12 (depends on 1)

The process according to claim 1 characterized in that the resulting cariprazine hydrochloride salts are converted into the base final product.

### Claim 13 (depends on 1)

The process according to claim 1 characterized in that from the isolated cariprazine borane adduct in conventional solvents by thermal decomposition the carprazine base final product is obtained.

### Claim 14

(Trans-4-{[(dimethyl-amino)carbonyl]amino}-cyclohexyl)-acetic acid.

### Claim 15

1,1-Dimethyl-3-[trans-4-(2-oxo-2-(4-(2,3-dichlorophenyl)piperazin-1-ylethyl)cyclohexyl] urea
cariprazine borane adduct of formula (2)
